Cell Therapeutics (CTIC) agrees to buy the worldwide rights to Pacritinib from S*Bio for $15M in...

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Cell Therapeutics (CTIC) agrees to buy the worldwide rights to Pacritinib from S*Bio for $15M in cash and $15M in preferred stock. Shares +6.1% premarket.